At a corporate symposium held in San Diego, Helixmith Co., Ltd. and Genopis, Inc. moved to launch a contract manufacturing business for plasmid DNA production.   Key executives and leadership members of Helixmith and Genopis attended the symposium to declare the launch of CDMO service in Q2 2020 using Genopis’ proprietary technology and the existing 500 liter reactor. Moving ahead, the company will establish additional smaller scale reactors (60-300 L, 6-30 L) with feasibility runs and s...